News
Novavax scores narrower Covid vaccine approval
Digest more
Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating ...
"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...
The US Food and Drug Administration changes Covid-19 vaccine approval process. Access to seasonal boosters is restricted for ...
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback